Live Breaking News & Updates on Human Immunology Biosciences Inc

Stay updated with breaking news from Human immunology biosciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug

Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Stockholm , Sweden , Swedish , Asahi-kasei , Natsuko-katsuki , Van-lanschot-kempen , Health-partners , Mariana-oncology-inc , Human-immunology-biosciences-inc , Novartis , Asahi-kasei-corp , Biogen-inc

HI-Bio Announces Positive Results From Phase 2 Study Of Felzartamab For Late Antibody-Mediated Rejection In Kidney Transplant Recipients

82% (n=9/11) of patients on felzartamab experienced resolution of antibody-mediated rejection per Banff criteria on biopsy at 24 weeks versus 20% (n ....

Stockholm , Sweden , United-states , Macau , China , Hong-kong , Vienna , Wien , Austria , Taiwan , Georg-bo , Uptal-patel

HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated Rejection in Kidney Transplant Recipients

HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated Rejection in Kidney Transplant Recipients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Stockholm , Sweden , China , Vienna , Wien , Austria , Macau , United-states , Hong-kong , Taiwan , Caroline-fry , Morgan-warners

HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress

HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Taiwan , United-states , Hong-kong , Stockholm , Sweden , Macau , China , Japan , Germany , Uptal-patel , Morgan-warners , Caroline-fry

Rare disease deal: Biogen buys Hibio for $1.15B up front

In a deal worth up to $1.8 billion, Biogen Inc. is buying Human Immunology Biosciences Inc. (Hibio), bolstering its late-stage immune-disease treatment portfolio and diversifying its pipeline. The massive amount comprises $1.15 billion up front and as much as $650 in potential milestone payments. ....

Biogen-inc , Human-immunology-biosciences-inc , Human-immunology-biosciences ,